Medtech secures £2m funding

A medtech spinout from the University of Warwick which is developing an innovative transdermal drug delivery patch technology has secured a £2m investment from specialist technology funder Mercia Technologies. Medherant, which is developing the TEPI Patch, received its first investment from Mercia's managed funds in 2015. Since then the company has developed an extensive patent estate and secured an exclusive worldwide licence from Bostik SA for the medical use of a novel adhesive. Mercia now holds a 33.6% direct equity sta... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
Close